Pfizer stock may not be cheap enough to buy yet, but it's certainly too cheap to sell.

Get the live share price of Pfizer Inc (PFE), including intraday charts, historical performance, key financials, and market ...

Why Pfizer (PFE) is on investors’ radar today Pfizer (PFE) is back in focus after recent share price moves, with the stock ...

Pfizer (PFE) is back in focus after reporting first quarter 2026 results that topped analyst expectations, reaffirmed its ...

Pfizer (PFE) closed at $26.14 in the latest trading session, marking a +2.11% move from the prior day. This move outpaced the S&P 500's daily gain of 1.75%. Elsewhere, the Dow gained 1.86%, while the ...

Promising clinical results in 2026 could set the stage for Pfizer's stock to rebound. However, the company's COVID-19 product and patent cliff challenges could prevent a big bounce this year. Even if ...

I last covered Pfizer Inc. stock (NYSE:PFE) on Feb 19. The article rated the stock as hold after examining its FQ4 earnings report (ER) and dividend declarations. Since then, a few new catalysts have ...

Pfizer offers a 6.3% yield, but its high dividend reflects weak growth prospects and looming patent cliffs. PFE’s dividend is currently covered by cash flow, but payout ratios are stretched, and ...

Pfizer (NYSE:PFE) will release its quarterly earnings report on Tuesday, 2026-02-03. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Pfizer to report an earnings ...

Track Pfizer share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...